ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 69 filers reported holding ALIGOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,124 | -39.6% | 22,924 | -21.4% | 0.00% | – |
| Q2 2023 | $28,337 | -43.0% | 29,183 | -48.7% | 0.00% | – |
| Q1 2023 | $49,693 | -42.3% | 56,857 | -37.1% | 0.00% | – |
| Q4 2022 | $86,159 | -37.1% | 90,418 | -27.3% | 0.00% | – |
| Q3 2022 | $137,000 | -41.9% | 124,426 | -36.3% | 0.00% | -100.0% |
| Q2 2022 | $236,000 | -45.9% | 195,412 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $436,000 | -45.5% | 202,692 | +200.9% | 0.00% | -50.0% |
| Q4 2021 | $800,000 | -42.6% | 67,369 | -25.0% | 0.00% | -33.3% |
| Q3 2021 | $1,394,000 | – | 89,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |